27th week of 2019 patent applcation highlights part 24 |
Patent application number | Title | Published |
20190202814 | PROCESSES FOR PREPARATION OF EMPAGLIFLOZIN | 2019-07-04 |
20190202815 | PIPERAZINE DERIVATIVE | 2019-07-04 |
20190202816 | METHODS OF SYNTHESIZING A DIFLUOROLACTAM ANALOG | 2019-07-04 |
20190202817 | COMPOUNDS FOR TREATING DEGENERATIVE DISEASES OF CENTRAL NERVOUS SYSTEM OR BRAIN TUMOR, AND USES THEREOF | 2019-07-04 |
20190202818 | PROCESSES FOR PREPARING ATR INHIBITORS | 2019-07-04 |
20190202819 | INDAZOLE SULFONAMIDE DERIVATIVES AS INVERSE AGONISTS OF RETINOID-RELATED ORPHAN RECEPTOR GAMMA (ROR GAMMA (T)) | 2019-07-04 |
20190202820 | PROCESS FOR PRODUCING FLUORINATED COMPOUNDS USING ALCOHOL SOLVENT HAVING CARBONYL GROUP | 2019-07-04 |
20190202821 | MONOCYCLIC COMPOUNDS USEFUL AS GPR120 MODULATORS | 2019-07-04 |
20190202822 | 8-(AZETIDIN-1-YL)-[1,2,4]TRIAZOLO[1,5-A]PYRIDINYL COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF | 2019-07-04 |
20190202823 | N-SULFONYLATED PYRAZOLO[3,4-b]PYRIDIN-6-CARBOXAMIDES AND METHOD OF USE | 2019-07-04 |
20190202824 | HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS | 2019-07-04 |
20190202825 | FLUORINATED IMIDAZO[4,5-C]QUINOLINE DERIVATIVES AS INHIBITORS OF BROMODOMAIN CONTAINING PROTEINS | 2019-07-04 |
20190202826 | Phosphotidylinositol 3-Kinase Inhibitors | 2019-07-04 |
20190202827 | FLUORINE-CONTAINING TRIAZOLOPYRIDINE, AND MANUFACTURING METHOD, PHARMACEUTICAL COMPOSITION, AND APPLICATION THEREOF | 2019-07-04 |
20190202828 | TRIAZOLOPYRIDINE COMPOUNDS AND USES THEREOF | 2019-07-04 |
20190202829 | PROCESS FOR PREPARING HALOGENATED PYRIDINE DERIVATIVES | 2019-07-04 |
20190202830 | INHIBITORS OF THE MENIN-MLL INTERACTION | 2019-07-04 |
20190202831 | PROCESS FOR PRODUCING CRYSTALS OF A DIAZABICYCLOOCTANE DERIVATIVE | 2019-07-04 |
20190202832 | BETA-LACTAMASE INHIBITOR COMPOUNDS | 2019-07-04 |
20190202833 | USE OF A DPP-4 INHIBITOR IN SIRS AND/OR SEPSIS | 2019-07-04 |
20190202834 | BARICITINIB INTERMEDIATE, METHOD FOR FORMING BARICITINIB INTERMEDIATE, AND METHOD FOR PREPARING BARICITINIB OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF | 2019-07-04 |
20190202835 | ISOTOPOLOGUES OF ISOQUINOLINONE AND QUINAZOLINONE COMPOUNDS AND USES THEREOF AS PI3K KINASE INHIBITORS | 2019-07-04 |
20190202836 | SELECTIVE DUAL INHIBITORS OF PI3 DELTA AND GAMMA PROTEIN KINASES | 2019-07-04 |
20190202837 | PROCESS FOR PREPARING SPIROKETAL-SUBSTITUTED CYCLIC KETOENOLS | 2019-07-04 |
20190202838 | ANTI-HCMV VIRUS COMPOUND | 2019-07-04 |
20190202839 | Novel Cytotoxic Agents And Conjugates Thereof | 2019-07-04 |
20190202840 | SALTS OF (S)-7-(1-(9H-PURIN-6-YLAMINO)ETHYL)-6-(3-FLUOROPHENYL)-3-METHYL-5- H-THIAZOLO[3,2-A]PYRIMIDIN-5-ONE | 2019-07-04 |
20190202841 | Novel 5,6-dihydro-4H-benzo[b]thieno-[2,3-d]azepine derivative | 2019-07-04 |
20190202842 | SCANDIUM PRECURSOR FOR SC2O3 OR SC2S3 ATOMIC LAYER DEPOSITION | 2019-07-04 |
20190202843 | SILICON BASED CYCLIC COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS FOR TREATING MALARIA AND TOXOPLASMOSIS | 2019-07-04 |
20190202844 | Silanes and Curable Compositions Comprising Said Silanes | 2019-07-04 |
20190202845 | SITE-SELECTIVE METAL PLATING ONTO A PACKAGE DIELECTRIC | 2019-07-04 |
20190202846 | HIGH-PURITY LARGE-SCALE PREPARATION OF STANNSOPORFIN | 2019-07-04 |
20190202847 | GROUP 5 METAL COMPOUND, METHOD FOR PREPARING THE SAME, PRECURSOR COMPOSITION FOR DEPOSITING LAYER CONTAINING THE SAME, AND METHOD FOR DEPOSITING LAYER USING THE SAME | 2019-07-04 |
20190202848 | Phosphepine Matrix Compound for a Semiconducting Material | 2019-07-04 |
20190202849 | METHOD FOR THE PREPARATION OF SUBSTITUTED THIOLACTONES, NEW SUBSTITUTED THIOLACTONES AND USES THEREOF | 2019-07-04 |
20190202850 | PHOSPHORESCENT LIGHT-EMITTING COMPLEX AND USE IN LIGHT-EMITTING DEVICE | 2019-07-04 |
20190202851 | BINUCLEAR AND TRINUCLEAR METAL COMPLEXES COMPOSED OF TWO INTER-LINKED TRIPODAL HEXADENTATE LIGANDS FOR USE IN ELECTROLUMINESCENT DEVICES | 2019-07-04 |
20190202852 | 2'-CHLORO AMINOPYRIMIDINONE AND PYRIMIDINE DIONE NUCLEOSIDES | 2019-07-04 |
20190202853 | DNA POLYMERASE BETA INHIBITORS | 2019-07-04 |
20190202854 | ENANTIOMERS OF THE 1',6'-ISOMER OF NEPLANOCIN A | 2019-07-04 |
20190202855 | POLYNUCLEOTIDE CONSTRUCTS | 2019-07-04 |
20190202856 | ENGINEERED CRISPR PROTEINS FOR COVALENT TAGGING NUCLEIC ACIDS | 2019-07-04 |
20190202857 | 3-(4'-SUBSTITUTED)-BENZYL-ETHER DERIVATIVES OF PREGNENOLONE | 2019-07-04 |
20190202858 | Aminosteroids for the Treatment of a PTP1B Associated Disease | 2019-07-04 |
20190202859 | PROTEIN PURIFICATION | 2019-07-04 |
20190202860 | PEPTIDE HAVING ANTICANCER ACTIVITY, AND PHARMACEUTICAL COMPOSITION, HEALTH FUNCTIONAL FOOD COMPOSITION AND FUNCTIONAL COSMETIC COMPOSITION FOR PREVENTING AND TREATING CANCER COMPRISING THE SAME AS ACTIVE INGREDIENT | 2019-07-04 |
20190202861 | N-CARBOXYANHYDRIDE-BASED-SCALE SYNTHESIS OF ELAMIPRETIDE | 2019-07-04 |
20190202862 | STAPLED AND STITCHED POLYPEPTIDES AND USES THEREOF | 2019-07-04 |
20190202863 | NOVEL CYCLIC PEPTIDES AND USES THEREOF | 2019-07-04 |
20190202864 | CYCLIC PEPTIDE, AFFINITY CHROMATOGRAPHY SUPPORT, LABELED ANTIBODY, ANTIBODY DRUG CONJUGATE, AND PHARMACEUTICAL PREPARATION | 2019-07-04 |
20190202865 | TARGETING DIMERIZATION OF BAX TO MODULATE BAX ACTIVITY | 2019-07-04 |
20190202866 | VIRAL NANOPARTICLES AND METHODS OF USE THEREOF | 2019-07-04 |
20190202867 | COMPOSITIONS AND METHODS FOR TREATING, INCLUDING PREVENTING, PARVOVIRUS INFECTIONS AND RELATED DISEASES | 2019-07-04 |
20190202868 | CORONAVIRUS PROTEINS AND ANTIGENS | 2019-07-04 |
20190202869 | THERAPEUTIC HPV18 VACCINES | 2019-07-04 |
20190202870 | HIV VACCINE FORMULATION | 2019-07-04 |
20190202871 | Mutated Immunoglobulin-Binding Protein Having Increased Alkaline Tolerance | 2019-07-04 |
20190202872 | PHENYLALANINE-FREE PROTEIN FOR THE TREATMENT OF PKU | 2019-07-04 |
20190202873 | COMPOSITIONS RELATING TO A MUTANT CLOSTRIDIUM DIFFICILE TOXIN AND METHODS THEREOF | 2019-07-04 |
20190202874 | METHOD OF MANUFACTURING RECOMBINANT LECTIN PROTEIN AND RECOMBINANT LECTIN PROTEIN MANUFACTURED BY USING THE SAME | 2019-07-04 |
20190202875 | IMMUNOGENIC PROTEINS AND FRAGMENTS THEREOF FROM ALLERGENIC MITES | 2019-07-04 |
20190202876 | MUTANT PORE | 2019-07-04 |
20190202877 | DERMASEPTIN-TYPE AND PISCIDIN-TYPE ANTIMICROBIAL PEPTIDES | 2019-07-04 |
20190202878 | COMPLEMENT INHIBITORS AND USES THEREOF | 2019-07-04 |
20190202879 | Bi-Functional Anti-Tau Polypeptides and Use Thereof | 2019-07-04 |
20190202880 | ADENO-ASSOCIATED VIRUS VECTOR DELIVERY OF B-SARCOGLYCAN AND MICRORNA-29 AND THE TREATMENT OF MUSCULAR DYSTROPHY | 2019-07-04 |
20190202881 | MOLECULES THAT SELECTIVELY ACTIVATE REGULATORY T CELLS FOR THE TREATMENT OF AUTOIMMUNE DISEASES | 2019-07-04 |
20190202882 | MOLECULES THAT SELECTIVELY ACTIVATE REGULATORY T CELLS FOR THE TREATMENT OF AUTOIMMUNE DISEASES | 2019-07-04 |
20190202883 | PEPTIDE COMPOUND | 2019-07-04 |
20190202884 | MODIFIED GLUCAGON MOLECULES | 2019-07-04 |
20190202885 | TauT (taurine transporter) peptide cancer vaccine | 2019-07-04 |
20190202886 | ONCOLYTIC VIRUSES COMPRISING esRAGE AND METHODS OF TREATING CANCER | 2019-07-04 |
20190202887 | Humanized Variable Lymphocyte Receptors (VLR) and Compositions and Uses Related Thereto | 2019-07-04 |
20190202888 | PEPTIDES HAVING EFFECTS OF PREVENTING OR TREATING CENTRAL NERVOUS SYSTEM DISEASES AND PHARMACEUTICAL COMPOSITIONS FOR PREVENTING OR TREATING CENTRAL NERVOUS SYSTEM DISEASES CONTAINING SAME AS ACTIVE INGREDIENT | 2019-07-04 |
20190202889 | CD80 EXTRACELLULAR DOMAIN POLYPEPTIDES AND THEIR USE IN CANCER TREATMENT | 2019-07-04 |
20190202890 | METHODS AND COMPOSITIONS RELATED TO ANTIGEN PRESENTING PROTEINS | 2019-07-04 |
20190202891 | GPR156 Variants And Uses Thereof | 2019-07-04 |
20190202892 | EXOSOMES FOR IMMUNO-ONCOLOGY AND ANTI-INFLAMMATORY THERAPY | 2019-07-04 |
20190202893 | VIRAL VECTORS ENCODING RECOMBINANT FVIII VARIANTS WITH INCREASED EXPRESSION FOR GENE THERAPY OF HEMOPHILIA A | 2019-07-04 |
20190202894 | TARGETED THERAPEUTICS BASED ON ENGINEERED PROTEINS FOR TYROSINE KINASES RECEPTORS, INCLUDING IGF-IR | 2019-07-04 |
20190202895 | COMPOSITIONS AND METHODS FOR TREATING HIV/AIDS WITH IMMUNOTHERAPY | 2019-07-04 |
20190202896 | ANTIBODIES AGAINST MICROORGANISMS AND USES THEREOF | 2019-07-04 |
20190202897 | METHODS AND COMPOSITIONS RELATED TO SOLUBLE MONOCLONAL VARIABLE LYMPHOCYTE RECEPTORS OF DEFINED ANTIGEN SPECIFICITY | 2019-07-04 |
20190202898 | AGLYCOSYLATED ANTI-C3b ANTIBODIES AND USES THEREOF | 2019-07-04 |
20190202899 | DOSING ALGORITHM FOR COMPLEMENT INHIBITOR | 2019-07-04 |
20190202900 | INHIBITORS OF C5A FOR THE TREATMENT OF VIRAL PNEUMONIA | 2019-07-04 |
20190202901 | COMPOSITION FOR THE TREATMENT OF IGF-1R EXPRESSING CANCER | 2019-07-04 |
20190202902 | ANTIBODY VARIANTS | 2019-07-04 |
20190202903 | ANTI-VEGF-A ANTIBODIES AND USES THEREOF | 2019-07-04 |
20190202904 | SYNTHETIC ANTIBODIES AGAINST VEGF AND THEIR USES | 2019-07-04 |
20190202905 | ANTIBODIES TO M-CSF | 2019-07-04 |
20190202906 | ANTIBODIES FOR IL-17C | 2019-07-04 |
20190202907 | METHOD OF TREATING SYSTEMIC FIBROTIC DISORDERS USING AN IL-33/TNF BISPECIFIC ANTIBODY | 2019-07-04 |
20190202908 | BI-SPECIFIC AGENTS | 2019-07-04 |
20190202909 | ANTIBODIES AGAINST FRIZZLED RECEPTOR | 2019-07-04 |
20190202910 | NOVEL SPECIFIC MONOCLONAL ANTIBODY TO ACETYLATED MOUSE BUBR1 AND PREPARATION METHOD THEREFOR | 2019-07-04 |
20190202911 | ANTIBODY FOR TREATING AUTOIMMUNE DISEASES | 2019-07-04 |
20190202912 | ANTIBODIES FOR SIGLEC-15 AND METHODS OF USE THEREOF | 2019-07-04 |
20190202913 | CHIMERIC ANTIGEN RECEPTORS TARGETING CD-19 | 2019-07-04 |